Title: "GEOCM04S1 vaccine candidate maintains potent crossreactivity against original SARSCoV2 B.1 and Omicron subvariant XBB.1.5." When: June 6, 2025 at 7:30 p.m. "These presentations underscore our ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cellino, a regenerative medicine company developing autonomous manufacturing systems for personalized cells, today announced that the company has been invited to ...

WASHINGTON, April 15, 2025 /PRNewswire/ -- June 4-7, 2025 – Keystone Symposia will host a timely meeting, "Vaccinology: Horizons Across Disease, Demography and Technology," in Washington, D.C., ...

Earlier this Spring, several members of the Stanford Cardiovascular Institute gathered with international experts in cardiovascular research at the Keystone Symposia Conference on Heart Development ...